Pacer Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.55M | Buy |
+556,730
| New | +$3.55M | 0.01% | 812 |
|
|
2024
Q3 | – | Sell |
-75
| Closed | -$512 | – | 2576 |
|
|
2024
Q2 | $512 | Buy |
75
+15
| +25% | +$102 | ﹤0.01% | 3717 |
|
|
2024
Q1 | $152 | Hold |
60
| – | – | ﹤0.01% | 3688 |
|
|
2023
Q4 | $144 | Sell |
60
-15
| -20% | -$36 | ﹤0.01% | 3519 |
|
|
2023
Q3 | $255 | Hold |
75
| – | – | ﹤0.01% | 2620 |
|
|
2023
Q2 | $551 | Buy |
75
+5
| +7% | +$37 | ﹤0.01% | 3521 |
|
|
2023
Q1 | $725 | Hold |
70
| – | – | ﹤0.01% | 2171 |
|
|
2022
Q4 | $827 | Sell |
70
-265,096
| -100% | -$3.13M | ﹤0.01% | 3302 |
|
|
2022
Q3 | $5.57M | Buy |
265,166
+265,054
| +236,655% | +$5.56M | 0.04% | 344 |
|
|
2022
Q2 | $3K | Hold |
112
| – | – | ﹤0.01% | 2325 |
|
|
2022
Q1 | $5K | Sell |
112
-27
| -19% | -$1.21K | ﹤0.01% | 2259 |
|
|
2021
Q4 | $6K | Sell |
139
-5,071
| -97% | -$219K | ﹤0.01% | 2178 |
|
|
2021
Q3 | $261K | Sell |
5,210
-1,595
| -23% | -$79.9K | ﹤0.01% | 1279 |
|
|
2021
Q2 | $429K | Buy |
6,805
+713
| +12% | +$44.9K | 0.01% | 1181 |
|
|
2021
Q1 | $566K | Sell |
6,092
-678
| -10% | -$63K | 0.01% | 1004 |
|
|
2020
Q4 | $607K | Sell |
6,770
-5,225
| -44% | -$468K | 0.01% | 894 |
|
|
2020
Q3 | $1.24M | Buy |
11,995
+11,943
| +22,967% | +$1.23M | 0.03% | 615 |
|
|
2020
Q2 | $4K | Buy |
+52
| New | +$4K | ﹤0.01% | 929 |
|
|
2019
Q1 | – | Sell |
-11,567
| Closed | -$686K | – | 751 |
|
|
2018
Q4 | $686K | Buy |
11,567
+8,454
| +272% | +$501K | 0.02% | 109 |
|
|
2018
Q3 | $205K | Buy |
+3,113
| New | +$205K | 0.01% | 1026 |
|
|
2018
Q2 | – | Sell |
-1,178
| Closed | -$62K | – | 1177 |
|
|
2018
Q1 | $62K | Buy |
1,178
+503
| +75% | +$26.5K | ﹤0.01% | 955 |
|
|
2017
Q4 | $31K | Buy |
+675
| New | +$31K | ﹤0.01% | 1062 |
|